Clinical Trials Browser

soluble LAG-3 protein, human × Dermatologic × Clear all

NCT01308294 2020-06-11

LAG-3/IMP321

Phase 1/2 Terminated

16 enrolled 12 charts

Melanoma

NCT02676869 2019-12-18

TACTI-mel

Phase 1 Completed

Melanoma

NCT00365937 2019-03-06

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Phase 1/2 Terminated

Melanoma